pharmaceutical innovation. The baseline estimate of the cost per life-year gained from pharmaceutical innovation in Greece is $17 …Longitudinal, disease-level data are used to analyze the impact of pharmaceutical innovation on longevity (mean age at … death), hospital utilization, and medical expenditure in Greece during the period 1995-2010. The estimates indicate that …

macroeconomics. The current policy, however, provides a credible platform for sustainable growth. Greece has entered the process of …-se determining growth, supply-side reforms and institutional performance are; and for Greece both are better served within the EMU …

of the restructuring left money on the table from the perspective of Greece, created a large risk for European taxpayers …

We describe the evolution of the power struggle in Greece among key economic and political stakeholders, who have tried …

and current account deficits, which have in turn driven Greece’s foreign indebtedness to alarming levels, necessitating …

Immigrants are widely perceived as being highly entrepreneurial and important for economic growth and innovation. This …

-return characteristics of the selected innovation project and the mode of commercialization chosen by entrepreneurs (market entry versus sale …